Efisio Puxeddu
Department of Internal Medicine
University of Perugia
Via Enrico dal Pozzo
06126 Perugia
Italy
Name/email consistency: high
- Clinical implications of BRAF mutation in thyroid carcinoma. Puxeddu, E., Durante, C., Avenia, N., Filetti, S., Russo, D. Trends Endocrinol. Metab. (2008)
- Clinical prognosis in BRAF-mutated PTC. Puxeddu, E., Moretti, S. Arq. Bras. Endocrinol. Metabol (2007)
- BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas. Puxeddu, E., Moretti, S., Elisei, R., Romei, C., Pascucci, R., Martinelli, M., Marino, C., Avenia, N., Rossi, E.D., Fadda, G., Cavaliere, A., Ribacchi, R., Falorni, A., Pontecorvi, A., Pacini, F., Pinchera, A., Santeusanio, F. J. Clin. Endocrinol. Metab. (2004)
- Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas. Puxeddu, E., Moretti, S., Giannico, A., Martinelli, M., Marino, C., Avenia, N., Cristofani, R., Farabi, R., Reboldi, G., Ribacchi, R., Pontecorvi, A., Santeusanio, F. Eur. J. Endocrinol. (2003)